Related references
Note: Only part of the references are listed.Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas
Deborah Y. Park et al.
JOURNAL OF NEURO-ONCOLOGY (2022)
KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis
Binbin Chen et al.
CELL DEATH & DISEASE (2022)
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA
Kenan Zhang et al.
CANCER BIOLOGY & MEDICINE (2022)
The BASP1 transcriptional corepressor modifies chromatin through lipid-dependent and lipid-independent mechanisms
Alexander J. Moorhouse et al.
ISCIENCE (2022)
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
Zewei Tu et al.
BMC CANCER (2022)
Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas
Zhumei Shi et al.
MOLECULAR CELL (2022)
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance
Manendra Singh Tomar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Genotoxic therapy and resistance mechanism in gliomas
Fengchao Lang et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Current status and recent advances in reirradiation of glioblastoma
Giuseppe Minniti et al.
RADIATION ONCOLOGY (2021)
Chinese Glioma Genome Atlas (CGGA) : A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
Zheng Zhao et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
High BASP1 Expression is Associated with Poor Prognosis and Promotes Tumor Progression in Human Lung Adenocarcinoma
Xin Wang et al.
CANCER INVESTIGATION (2021)
Immunotherapy for recurrent glioblastoma: practical insights and challenging prospects
Xin Wang et al.
CELL DEATH & DISEASE (2021)
Cholesterol is required for transcriptional repression by BASP1
Amy E. Loats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma
Shaofang Wu et al.
NEURO-ONCOLOGY (2021)
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Barbara Oldrini et al.
NATURE COMMUNICATIONS (2020)
BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt/β-Catenin Pathway in Gastric Cancer
Li Li et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
Larraitz Egana et al.
SCIENTIFIC REPORTS (2020)
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
Ching-Chan Lin et al.
THERANOSTICS (2020)
ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
Bo Han et al.
THERANOSTICS (2020)
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges
Alireza Mansouri et al.
NEURO-ONCOLOGY (2019)
A Unique Family of Neuronal Signaling Proteins Implicated in Oncogenesis and Tumor Suppression
Markus Hartl et al.
FRONTIERS IN ONCOLOGY (2019)
PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation
Shao-Ming Shen et al.
NATURE CELL BIOLOGY (2019)
Glioma Grade Discrimination with MR Diffusion Kurtosis Imaging: A Meta-Analysis of Diagnostic Accuracy
Anna Falk Delgado et al.
RADIOLOGY (2018)
Primary brain tumours in adults
Sarah Lapointe et al.
LANCET (2018)
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Xiaoyue Chen et al.
NATURE COMMUNICATIONS (2018)
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
Xing Liu et al.
NEUROIMAGE-CLINICAL (2018)
Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression
Da Zhou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
BASP1 interacts with oestrogen receptor α and modifies the tamoxifen response
Lindsey A. Marsh et al.
CELL DEATH & DISEASE (2017)
Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22
Aidong Zhou et al.
NATURE CELL BIOLOGY (2016)
Histone Modifications and Cancer
James E. Audia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide
Khaled Messaoudi et al.
DRUG DISCOVERY TODAY (2015)
Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping
Yinyan Wang et al.
NEURO-ONCOLOGY (2015)
Emerging treatment strategies for glioblastoma multiforme
Steven K. Carlsson et al.
EMBO MOLECULAR MEDICINE (2014)
TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein
Sanchita Bhatnagar et al.
NATURE (2014)
Prohibitin is required for transcriptional repression by the WT1-BASP1 complex
E. Toska et al.
ONCOGENE (2014)
Understanding and Targeting Alkylator Resistance in Glioblastoma
Wolfgang Wick et al.
CANCER DISCOVERY (2014)
NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)
Luciana O. Almeida et al.
FEBS OPEN BIO (2014)
O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
C-H Fan et al.
CELL DEATH & DISEASE (2013)
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Consolacion Melguizo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Repression of Transcription by WT1-BASP1 Requires the Myristoylation of BASP1 and the PIP2-Dependent Recruitment of Histone Deacetylase
Eneda Toska et al.
CELL REPORTS (2012)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
